Table 3.
Adverse Events Reported By At Least 5% of Participants During Treatment
Adverse Event | Selegiline | Placebo |
---|---|---|
Insomnia | 47.1% | 42.6% |
Headache | 33.9% | 35.2% |
Skin rash | 24.8% | 20.5% |
Racing thoughts | 20.7% | 23.0% |
Lightheaded | 16.5% | 16.4% |
Vivid Dreams | 10.7% | 9.8% |
Other | 42% | 35% |
No effects of treatment: all p-values > .05